Evidence map›Paper›PMID 20600172›Full record

ArticleNeuropharmacology2010

Glycogen synthase kinase-3 and p38 MAPK are required for opioid-induced microglia apoptosis.

Nanchang Xie, Hui Li, Dailin Wei, Gene LeSage, Lin Chen, Shengjun Wang, Yi Zhang, Lingyi Chi, Kenneth Ferslew, Lei He and 2 more

Open access · greenAbstract read
In one paragraph

Article in Neuropharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Neuroprotective effects ofJournal of pharmaceutical analysis · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Nanchang XieDepartment of Neurology, Qilu Hospital, Shandong University, Jinan 250012, China.
Hui Li
Dailin Wei
Gene LeSage
Lin Chen
Shengjun Wang
Yi Zhang
Lingyi Chi
Kenneth Ferslew
Lei He
Zhaofu Chi
Deling Yin
East Tennessee State University · USQilu Hospital of Shandong University · CNTaian City Central Hospital · CN

Funding

ROLE OF OPIOIDS SIGNALING IN IMMUNE SUPPRESSIONR15DA020120 · NIDA · EAST TENNESSEE STATE UNIVERSITY · PI YIN, DELING · 2005 to 2011
$859k
NIDA NIH HHS DA020120-03A1NIDA NIH HHS R15 DA020120
6 · The paper itself

Abstract

Opioids have been widely applied in clinics as one of the most potent pain relievers for centuries, but their abuse has deleterious physiological effects beyond addiction. We previously reported that opioids inhibit cell growth and trigger apoptosis in lymphocytes. However, the underlying mechanism by which microglia apoptosis in response to opioids is not yet known. In this study, we show that morphine induces microglia apoptosis and caspase-3 activation in an opioid-receptor dependent manner. Morphine decreased the levels of microglia phosphorylated Akt (p-Akt) and p-GSK-3β (glycogen synthase kinase-3 beta) in an opioid-receptor dependent manner. More interestingly, GSK-3β inhibitor SB216763 significantly increases morphine-induced apoptosis in both BV-2 microglia and mouse primary microglial cells. Moreover, co-treatment of microglia with SB216763 and morphine led to a significant synergistic effect on the level of phospho-p38 mitogen-activated protein kinase (MAPK). In addition, inhibition of p38 MAPK by its specific inhibitor SB203580 significantly inhibited morphine-induced apoptosis and caspase-3 activation. Taken together, our data clearly demonstrates that morphine-induced apoptosis in microglial cells, which is mediated via GSK-3β and p38 MAPK pathways.

Indexed as

Analgesics, OpioidAnalysis of VarianceAnimalsApoptosisbcl-2-Associated X ProteinBlotting, WesternCells, CulturedCell SurvivalGlycogen Synthase Kinase 3In Situ Nick-End LabelingMiceMice, Inbred BALB CMicrogliaMorphinep38 Mitogen-Activated Protein KinasesPhosphorylationAnalgesics, OpioidBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseGlycogen Synthase Kinase 3Morphinep38 Mitogen-Activated Protein KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-bcl-2

Identifiers

PMID20600172
PMCPMC2946474
OpenAlexW2019494632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.